Concepedia

Preeti Shah

PS

Statistics

Publications

19

Citations

1K

H-Index

16

Active since

2004

Affiliations

University of Maryland, Baltimore(Current)

Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins University

Loyola University Maryland

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Preeti Shah is an author at University of Maryland, Baltimore specializing in medicine, oncology, and molecular oncology.

Publications per year

2004–2018

19

Publications

19

Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study

Hans J. Hammers, Henk M.W. Verheul, Brenda Salumbides et al. · Molecular Cancer Therapeutics · 2010 · 171 citations · Full text

, , +17

High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition

Ola Awad, Jason T. Yustein, Preeti Shah et al. · PLoS ONE · 2010 · 158 citations · Full text

, , +17

Integrated preclinical and clinical development of S-trans, trans-farnesylthiosalicylic acid (FTS, Salirasib) in pancreatic cancer

Daniel A. Laheru, Preeti Shah, N.V. Rajeshkumar et al. · Investigational New Drugs · 2012 · 104 citations

, , +7

Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells

Amanda Schech, Armina A. Kazi, Stephen Yu et al. · Molecular Cancer Therapeutics · 2015 · 96 citations · Full text

, , +15

Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin

Preeti Shah, Gauri Sabnis · Breast Cancer Research and Treatment · 2013 · 87 citations

, , +16

1–5 of 19